Sarepta Therapeutics Inc (SRPT) Insider Trading
- $26,653,814.18
- $14,859,236.58
- Dec. 12, 2024
- Michael Andrew Chambers
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 12, 2024 | Director | 10,500 | $124.84 | Sell | $1,310,820.00 | |
| Dec. 5, 2024 | Director | 1,636 | $125.55 | Sell | $205,399.80 | |
| Aug. 30, 2024 | CFO | 5,985 | $137.36 | Sell | $822,099.60 | |
| Aug. 16, 2024 | Director | 37,038 | $133.80 | Buy | $4,955,684.40 | |
| June 25, 2024 | EVP | 38,957 | $161.61 | Sell | $6,295,840.77 | |
| June 24, 2024 | Insider | 7,859 | $163.08 | Sell | $1,281,645.72 | |
| May 2, 2024 | Insider | 3,635 | $140.00 | Sell | $508,900.00 | |
| March 11, 2024 | Director | 761 | $122.93 | Sell | $93,549.73 | |
| March 8, 2024 | Director | 15,000 | $123.25 | Sell | $1,848,750.00 | |
| March 5, 2024 | Director | 3,135 | $122.96 | Sell | $385,479.60 | |
| March 1, 2024 | Insider | 2,000 | $128.84 | Sell | $257,680.00 | |
| March 1, 2024 | CFO | 1,200 | $128.30 | Sell | $153,960.00 | |
| Nov. 3, 2023 | Director | 50,000 | $78.81 | Buy | $3,940,500.00 | |
| Nov. 3, 2023 | CEO | 25,225 | $79.36 | Buy | $2,001,856.00 | |
| Aug. 14, 2023 | Director | 9,979 | $109.47 | Buy | $1,092,401.13 | |
| Aug. 10, 2023 | Director | 34,867 | $106.15 | Buy | $3,701,132.05 | |
| Aug. 4, 2023 | Director | 15,000 | $106.72 | Sell | $1,600,800.00 | |
| Nov. 17, 2022 | Director | 858 | $109.92 | Sell | $94,311.36 | |
| Sept. 14, 2022 | Director | 57,100 | $104.43 | Buy | $5,962,953.00 | |
| Aug. 19, 2022 | Director | 46,170 | $108.28 | Buy | $4,999,287.60 |
Insiders are both buying and selling Sarepta Therapeutics Inc stock.
The insider traders at Sarepta Therapeutics Inc are: Michael Andrew Chambers, Hans Lennart Rudolf Wigzell, Stephen Mayo, Ian Michael Estepan, Kathryn Jean Boor, Bilal Arif, Dallan Murray, Douglas S Ingram, Richard Barry, and Ryan Edward Brown
The most active insider trader at Sarepta Therapeutics Inc is Michael Andrew Chambers with 5 trades.
Ryan Edward Brown has sold the most Sarepta Therapeutics Inc stock with a total value of $12,591,681.54.
Michael Andrew Chambers has bought the most Sarepta Therapeutics Inc stock with a total value of $25,667,142.58.
The most recent insider trade for Sarepta Therapeutics Inc was on Dec. 12, 2024.
The single biggest insider buy for Sarepta Therapeutics Inc was from Michael Andrew Chambers with a total value of $5,962,953.00 on Sept. 14, 2022.
The single biggest insider sell for Sarepta Therapeutics Inc was from Ryan Edward Brown with a total value of $6,295,840.77 on June 25, 2024.